Control of blood vessels can treat obesity

Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Focusing on Medicon Valley

Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...

Major changes to the Q-Med board

The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.

Spinnkolonner utvecklade speciellt för ChIP

Isolering av DNA baserat på antikroppsinbindning till kromatin är ett effektivt verktyg för att studera det DNA som finns i närheten av de målproteiner som anti...

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Welcome to wonderful Copenhagen

Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...

Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

System för bildtagning anpassat för life science

Bildåtergivning. Gel logic 4000 pro är en helautomatiserad plattform för luminiscent, fluorescent, ultraviolett och radioisotop bildtagning som utvecklats speci...

Vitrolife wants to acquire Medicult

The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.

Bioläkemedel är här för att stanna

Småmolekyler fortsätter att dominera men chansen för ett bioläkemedel att nå ända fram är dubbelt så stort som för kemiska läkemedel.

Personligt om Kina

Sylvia Schwaag Serger, internationell strateg på Vinnova, sommarpratar i P1 den 6 juli.

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

An industry emerging from crisis

"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Ökade vårdkostnader i Europa kräver långsiktiga satsningar på innovation

Anna Nilsson Vindefjärd, Generalsekreterare på Forska Sverige.

Schizophrenia and bipolar disorder are relatives

Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

LEO Pharma - International Clinical Trial Manager

Lundbeck divests companies

The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.

IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm

Platform for high security virus purification

Millipore Corporation has introduced the Viresolve Pro Solution system, a new system for purification of viruses. The technology in the new platform includes a ...